Literature DB >> 20186874

De-stigmatising human papillomavirus in the context of cervical cancer: a randomised controlled trial.

Tracy T C Kwan1, Kar-Fai Tam, Peter W H Lee, Sue S T Lo, Karen K L Chan, Hextan Y S Ngan.   

Abstract

OBJECTIVE: To identify the components of a human papillomavirus (HPV) message contributing to reducing the stigma of HPV in cervical cancer.
METHODS: 294 ethnic Chinese women attending a community-based clinic in Hong Kong were randomly allocated to read one of three written HPV messages: Group 'lr+hrHPV': low-risk and high-risk HPVs facts, Group 'hrHPV': high-risk HPV facts only and Group 'ds+hrHPV': high-risk HPV facts and de-stigmatising components, namely being anti-stereotypical, motivational and low in complexity. Main outcome measures were high-risk HPV-related sexual stigma, knowledge, attitude towards message, and intention to be HPV-tested measured by self-administered questionnaires immediately before and after reading.
RESULTS: Message allocation had a significant effect on sexual stigma (F = 5.219, p = 0.006). Participants who read message ds+hrHPV showed the least stigma, and were significantly less likely to believe that high-risk HPV infection implicated promiscuity, non-monogamy or that monogamy offered complete protection against high-risk HPV. The genital HPV-focused message was more stigmatising than cervical cancer-focused messages. Of all participants, 93% (237/254) and 97% (260/269) indicated a positive intention to be HPV-tested before and after reading, respectively. There were no between-group differences noted in terms of knowledge and intention to be HPV-tested before or after reading.
CONCLUSIONS: Our findings show that an HPV message containing specific de-stigmatising components may reduce public stigma towards high-risk HPV. Also, focusing solely on high-risk HPV in the context of cervical cancer helps to avoid the stigmatising effect of genital warts from tainting perceptions about high-risk HPV infection.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20186874     DOI: 10.1002/pon.1706

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  6 in total

1.  Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results.

Authors:  Andrea Krawczyk; Samara Perez; Leonora King; Maryline Vivion; Eve Dubé; Zeev Rosberger
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Increasing Cervical Cancer Prevention Through HPV Testing: Challenges in Developing Persuasive Messages.

Authors:  Mark Dignan; Aaron Kruse-Diehr
Journal:  Cancer Prev Res (Phila)       Date:  2021-09

3.  Development of a cross-cultural HPV community engagement model within Scotland.

Authors:  Elaine Carnegie; Anne Whittaker; Carol Gray Brunton; Rhona Hogg; Catriona Kennedy; Shona Hilton; Seeromanie Harding; Kevin G Pollock; Janette Pow
Journal:  Health Educ J       Date:  2017-01-23

4.  The ENHANCES study--Enhancing Head and Neck Cancer patients' Experiences of Survivorship: study protocol for a randomized controlled trial.

Authors:  Jane Turner; Patsy Yates; Lizbeth Kenny; Louisa G Gordon; Bryan Burmeister; Damien Thomson; Brett Hughes; Alexandra L McCarthy; Chris Perry; Raymond J Chan; Alana Fraser; Helen Skerman; Martin Batstone; Kathryn Carswell
Journal:  Trials       Date:  2014-05-28       Impact factor: 2.279

Review 5.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04

6.  Report from a symposium on catalyzing primary and secondary prevention of cancer in India.

Authors:  Suneeta Krishnan; Preet K Dhillon; Afsan Bhadelia; Anna Schurmann; Partha Basu; Neerja Bhatla; Praveen Birur; Rajeev Colaco; Subhojit Dey; Surbhi Grover; Harmala Gupta; Rakesh Gupta; Vandana Gupta; Megan A Lewis; Ravi Mehrotra; Ann McMikel; Arnab Mukherji; Navami Naik; Laura Nyblade; Sanghamitra Pati; M Radhakrishna Pillai; Preetha Rajaraman; Chalurvarayaswamy Ramesh; G K Rath; Richard Reithinger; Rengaswamy Sankaranarayanan; Jerard Selvam; M S Shanmugam; Krithiga Shridhar; Maqsood Siddiqi; Linda Squiers; Sujha Subramanian; Sandra M Travasso; Yogesh Verma; M Vijayakumar; Bryan J Weiner; K Srinath Reddy; Felicia M Knaul
Journal:  Cancer Causes Control       Date:  2015-09-03       Impact factor: 2.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.